These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 19852905)

  • 1. Generalizability of the results of efficacy trials in first-episode schizophrenia: comparisons between subgroups of participants of the European First Episode Schizophrenia Trial (EUFEST).
    Boter H; Derks EM; Fleischhacker WW; Davidson M; Kahn RS;
    J Clin Psychiatry; 2010 Jan; 71(1):58-65. PubMed ID: 19852905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpreting and applying the EUFEST results using number needed to treat: antipsychotic effectiveness in first-episode schizophrenia.
    Citrome L
    Int J Clin Pract; 2008 May; 62(5):837-40. PubMed ID: 18412940
    [No Abstract]   [Full Text] [Related]  

  • 3. What do large scale studies of medication in schizophrenia add to our management strategies?
    Agius M; Davis A; Gilhooley M; Chapman S; Zaman R
    Psychiatr Danub; 2010 Jun; 22(2):323-8. PubMed ID: 20562774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex selection bias in schizophrenia antipsychotic trials.
    Chaves AC; Seeman MV
    J Clin Psychopharmacol; 2006 Oct; 26(5):489-94. PubMed ID: 16974190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating characteristics of patient selection and dropout rates.
    Keith SJ
    J Clin Psychiatry; 2001; 62 Suppl 9():11-4; discussion 15-6. PubMed ID: 11379825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of treatment effects in schizophrenia.
    Stroup TS
    Am J Med; 2007 Apr; 120(4 Suppl 1):S26-31. PubMed ID: 17403379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in concomitant medication with benzodiazepines or antidepressants in first-break schizophrenic patients treated with antipsychotic medication.
    Rijcken CA; Knegtering H; Bruggeman R; Tobi H; de Jong-van den Berg LT
    Psychiatry Res; 2005 Apr; 134(2):143-50. PubMed ID: 15840415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [May results from randomized clinical trials be generalized? An example from psychopharmacology].
    Licht RW; Gouliaev GH; Vestergaard P; Frydenberg M
    Ugeskr Laeger; 1998 Jul; 160(30):4419-23. PubMed ID: 9691834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study.
    Ward A; Ishak K; Proskorovsky I; Caro J
    Clin Ther; 2006 Nov; 28(11):1912-21. PubMed ID: 17213012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suicide risk in placebo vs active treatment in placebo-controlled trials for schizophrenia.
    Storosum JG; van Zwieten BJ; Wohlfarth T; de Haan L; Khan A; van den Brink W
    Arch Gen Psychiatry; 2003 Apr; 60(4):365-8. PubMed ID: 12695313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
    Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-generation antipsychotics for schizophrenia: can we resolve the conflict?
    Leucht S; Kissling W; Davis JM
    Psychol Med; 2009 Oct; 39(10):1591-602. PubMed ID: 19335931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of clinical characteristics and antipsychotic medication prescribing practices of first-episode schizophrenia in Israel: a naturalistic prospective study.
    Strous RD; Bar F; Keret N; Lapidus R; Kosov N; Chelben J; Kotler M
    Isr J Psychiatry Relat Sci; 2006; 43(1):2-9. PubMed ID: 16910378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG; Kopala LC; Rabinowitz J
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment response trajectories and their antecedents in recent-onset psychosis: a 2-year prospective study.
    Levine SZ; Rabinowitz J; Case M; Ascher-Svanum H
    J Clin Psychopharmacol; 2010 Aug; 30(4):446-9. PubMed ID: 20631562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
    Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM
    J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
    Gaebel W; Möller HJ; Buchkremer G; Ohmann C; Riesbeck M; Wölwer W; Von Wilmsdorff M; Bottlender R; Klingberg S
    Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance abuse in clozapine-treated schizophrenic patients.
    Sand PG; Soyka M
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):626-7. PubMed ID: 9447510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.